Skip to content
  • Home
  • World News
  • Business
  • Aviation
195 news

195News

All the news that's fit to print

  • Home
  • World News
  • Business
  • Aviation
  • Toggle search form
  • Empowering Projects and Teams, PPM Express Now Integrates Monday.com
    Empowering Projects and Teams, PPM Express Now Integrates Monday.com World News
  • Secretary Blinken’s Meeting with Ethiopian Deputy Prime Minister and Minister of Foreign Affairs Mekonnen
    Secretary Blinken’s Meeting with Ethiopian Deputy Prime Minister and Minister of Foreign Affairs Mekonnen World News
  • Soon-To-Be-Released Spy Aided by Secret Ally During “Mole Hunt”
    Soon-To-Be-Released Spy Aided by Secret Ally During “Mole Hunt” World News
  • ZeroFlucs Adds Former Don Best Sports Managing Director Benjie Cherniak as Strategic Advisor
    ZeroFlucs Adds Former Don Best Sports Managing Director Benjie Cherniak as Strategic Advisor Business
  • War Day 160: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych  & #Feygin
    War Day 160: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin World News
  • Karns & Karns Personal Injury and Accident Attorneys Expands Southern California Presence with New Santa Monica Office
    Karns & Karns Personal Injury and Accident Attorneys Expands Southern California Presence with New Santa Monica Office Business
  • Drone Light Shows Market Is Thriving Worldwide Expected to Witness Significant Growth Between 2021 to 2031
    Drone Light Shows Market Is Thriving Worldwide Expected to Witness Significant Growth Between 2021 to 2031 Business
  • Readout of Secretary Mayorkas’s Visit to Poland
    Readout of Secretary Mayorkas’s Visit to Poland World News
Envision Pharma Group Acquires OKRA.ai

Envision Pharma Group Acquires OKRA.ai

Posted on February 7, 2023 By NewsEditor
Envision Pharma Group Acquires OKRA.aiEnvision Pharma Group Acquires OKRA.aiPivotal acquisition in Envision Pharma Group's tech-enabled offerings provides clients with access to advanced AI to accelerate decision-making that optimizes their products' path to market and ultimately supports the delivery of enhanced patient outcomes.

PHILADELPHIA, February 7, 2023 (Newswire.com) - Envision Pharma Group (Envision), a leading global technology-enabled commercialization, integrated medical capabilities and solutions, and data analytics partner to the life sciences industry, announced today it has acquired OKRA.ai, an award-winning technology company active in the provision of artificial intelligence (AI) solutions with present brains across commercialization, real-world evidence and data analytics, medical, and pricing for the pharmaceutical and life sciences industry. 

OKRA.ai's AI products and solutions translate large clinical, scientific, and commercial data sets into actionable insights to empower decision-making and drive action to clients in the life sciences industry.

"We are delighted to welcome OKRA.ai into the Envision Pharma Group family," shares Meg Heim, CEO, Envision Pharma Group. "The acquisition of OKRA.ai marks an exciting milestone in Envision's evolution as we continue to accelerate and deliver a compelling combination of technology-enabled capabilities and solutions to clients. The combination of Envision's leading technology, capabilities, and solutions with OKRA.ai's artificial intelligence solutions and expertise enables us to strengthen our offerings to clients across the product life cycle, but more importantly, support patients in their journey to health and wellness."  

Dr. Loubna Bouarfa, founder of OKRA.ai, will be joining Envision as a member of its Executive Leadership Team. Recently, Loubna won the prestigious Deloitte Fast 50 Women in Leadership Award and Forbes 50 Top Women in Tech. Loubna shares, "Today is a redefining moment for OKRA.ai. I am honored to be joining forces with Envision and see enormous opportunities for the growth of our combined expertise and solutions for clients in the life sciences industry. As part of Envision Pharma Group, we can accelerate our work to bring AI to the heart of decision-making across the life sciences industry. Our success will not only bring commercial benefit to clients but lead to improved patient outcomes across the globe." 

Based in the U.K. and Netherlands, OKRA.ai employs around 30 members of staff. The acquisition of OKRA.ai will bring the total number of Envision Pharma Group to 1,400+ employees across four continents.  

About Envision Pharma Group
Founded in 2001, Envision Pharma Group is a leading global technology-enabled strategic solutions partner for the life sciences industry, working with over 200 pharma and biotech companies, including 18 of the top 20 pharmaceutical companies. Envision supports clients across the product lifecycle through a comprehensive suite of services and industry-leading technology solutions: including evidence-based scientific communications and engagement; commercialization and integrated medical consultancy; and HEOR/market access and data analytics capabilities. Learn more at www.envisionpharmagroup.com

About OKRA.ai 
OKRA.ai is a pioneer in developing AI solutions for the life sciences industry, bringing self-learning AI to optimize commercial, medical and market access decision making. Through its product portfolio, OKRA.ai delivers AI solutions to empower pharmaceutical companies with predictions and suggestions to bring novel treatments to patients in an efficient and effective way. 

OKRA.ai was founded by Dr. Loubna Bouarfa in 2015 with a vision of moving the healthcare industry towards data-driven decision-making by explainable AI. Since then, OKRA.ai has been instrumental in building industry-first Explainable AI which empowers users by providing explanations behind predictions and suggestions. OKRA.ai currently consists of a highly qualified workforce across the UK and the Netherlands and has a nearly equal gender balance (48% of staff are female). 

OKRA.ai's solution suite compiles healthcare data from multiple sources, with coverage across hundreds of therapeutic areas, thousands of clinical trials and publications, millions of medically relevant free text and billions of data points that are specific to patient demographics. Since 2015, OKRA.ai has supported the commercialization of 92 molecules, 67 indications and 13 pharmaceutical brands.

Contact Information:
Colleen Carter
Communications
[email protected]
1 (203) 480 0080


Original Source: Envision Pharma Group Acquires OKRA.ai Envision Pharma Group Acquires OKRA.ai
Business

Post navigation

Previous Post: Under Secretary Zeya’s Travel to Ulaanbaatar, Mongolia and Tokyo, Japan
Next Post: General Communication Equipment Market Size, Share And Growth Analysis For 2023-2032

Related Posts

  • clean.io Launches Free ‘Coupon Detective’ Report for E-commerce Merchants
    clean.io Launches Free ‘Coupon Detective’ Report for E-commerce Merchants Business
  • Frost & Sullivan selects CareAR for the 2023 Enabling Technology Leadership Award in Augmented Reality
    Frost & Sullivan selects CareAR for the 2023 Enabling Technology Leadership Award in Augmented Reality Business
  • Prospector and TMX Datalinx Sign Reseller Agreement for Canadian Market
    Prospector and TMX Datalinx Sign Reseller Agreement for Canadian Market Business
  • How John Gaule Nutrition is Helping Athletes across Ireland with Sports Nutrition
    How John Gaule Nutrition is Helping Athletes across Ireland with Sports Nutrition Business
  • Savvy Cleaner Strikes Gold on Live Shopping Show With New Assistant Producer Jenifer Holland
    Savvy Cleaner Strikes Gold on Live Shopping Show With New Assistant Producer Jenifer Holland Business
  • Sports Industry Marks August 18th as Never Give Up Day
    Sports Industry Marks August 18th as Never Give Up Day Business
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
« May    
last celebrity gossip
Gossip Stone - celebrity life and gossip

Recent Posts

  • Terradepth awarded 5-year contract in global offshore energyJune 4, 2025
  • Artem Mirolevich and Dmitry Trekhsvyatsky Launch Bold New ExhibitionJune 4, 2025
  • Global Data Systems Appoints Doug Pickle as President, Driving Strategic GrowthJune 4, 2025
  • Smith Earns ISO/IEC 17025 AS6171 Accreditation at Its Global Operational HubsJune 3, 2025
  • Trends, Growth, and Insights Through 2034June 3, 2025
Brand Values Content
VUGA Enterprises - media network PR & Marketing
  • From Sea to Shining Sea -Events That Offer Hope are Set to Culminate with ‘The Best You’ Expo in Los Angeles-March 3-5
    From Sea to Shining Sea -Events That Offer Hope are Set to Culminate with ‘The Best You’ Expo in Los Angeles-March 3-5 World News
  • Satellite Communication Market Size to Reach USD 70.89 Billion by 2032, Growing at a CAGR of 9.6%
    Satellite Communication Market Size to Reach USD 70.89 Billion by 2032, Growing at a CAGR of 9.6% Aviation
  • Global Hydrogen Energy Storage Market Drivers, Trends And Restraints For 2022-2031
    Global Hydrogen Energy Storage Market Drivers, Trends And Restraints For 2022-2031 World News
  • StudyLingua macht Sprachreisen zum echten Lernerlebnis
    StudyLingua macht Sprachreisen zum echten Lernerlebnis World News
  • War Day 229: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin
    War Day 229: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin World News
  • TRIDENT Refit Facility Honored with 2024 Best of Georgia Award
    TRIDENT Refit Facility Honored with 2024 Best of Georgia Award Aviation
  • Lacie Blue Signs Record Deal with Nashville Label, Clinetel Records
    Lacie Blue Signs Record Deal with Nashville Label, Clinetel Records World News
  • War Day 75: war diaries w/ Advisor to Ukraine President, Intel Officer @Alexey Arestovych & #Фейгин
    War Day 75: war diaries w/ Advisor to Ukraine President, Intel Officer @Alexey Arestovych & #Фейгин World News
aerospace company
stem cell clinic in kiev
medical spa in miami
Fashion TV free

Copyright © 2023 195 News. All Rights Reserved by Coolaser | Partner of VUGA Enterprises |  Advertising: Get Published

Powered by .